CD33 and Alzheimer disease: The levels of CD33, a sialoadhesion expressed by monocytes and macrophages and recently shown to be associated with late-onset Alzheimer’s disease and the scavenger receptor CD36 varied between donors (1-74%, CD33; 8-89%, CD36) (Figure 2).